The Changing Landscape of Preventative Migraine Treatments
A panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.
Headache Specialists for Preventative Migraine Treatments
A discussion on when a patient should be referred to a headache specialist for preventive migraine treatment.
Preventative Migraine Therapies: The ADVANCE Trial and the Future
Jessica Ailani, MD, details how the phase 3 ADVANCE trial will shape the research of future agents for preventive migraine treatment.
Oral Agents for Preventative Migraine Treatment
A key opinion leader discusses the use of oral agents for the preventive treatment of migraine.
CGRP Monoclonal Antibodies and Patient Treatment Selection
Dr Christopher Gottschalk shares how the clinical trial data for CGRP monoclonal antibodies affect patient selection for preventive migraine treatment.
CGRP Monoclonal Antibodies: A Review of Trial Data
A panel of neurologists review clinical trial data on several CGRP monoclonal antibodies for migraine preventive treatment.
Preventing Migraine with CGRP Monoclonal Antibodies
Expert neurologists discuss the use of CGRP monoclonal antibodies to prevent migraines.
OnabotulinumtoxinA for Preventative Migraine Treatment
Stephanie J. Nahas, MD, MSEd, FAHS, FAAN, provides an overview of the use of onabotulinumtoxinA as a preventive migraine treatment.
Discussing Novel Agents for Preventative Migraine Therapy with Patients
A thought leader explains how she involves the patient when selecting novel agents to add to a preventive migraine treatment plan.
Preventative Migraine Therapy: Novel Agents
An introduction to the use of novel agents for preventive migraine therapy.
Behavioral Treatment Strategies for Migraine Management
An expert panel discusses migraine prevention with the use of behavioral therapies such as cognitive behavioral therapy and stress management.
Discussing Preventative Migraine Lifestyle Changes with Patients
Dr Andrew Charles shares how he eases patient anxieties over lifestyle changes for preventive migraine therapy.
Non-Drug Therapies for Migraine Prevention: Lifestyle Changes
Rebecca Erwin Wells, MD, MPH, details the effectiveness of lifestyle changes for preventative migraine treatment.
Measuring Success in Migraine Preventative Treatment
A discussion on how to measure the success of preventative migraine treatment.
Migraine Preventative Treatment and Burden of Disease
Key opinion leaders explain the burden of disease that accompanies preventative migraine treatment.
Goals of Preventative Therapy for Migraine
Expert neurologists share their goals and patient considerations for preventive migraine therapy.
Migraine: A Historic Perspective on Preventative Therapy
Andrew C. Charles, MD, provides a historical perspective on the agents traditionally used for preventive migraine therapy.
Christopher Gottschalk, MD: Long-Term Safety in Preventive Migraine Therapies
The director of headache medicine and chief of general neurology at Yale Medicine discussed the long-term success the new preventive migraine therapies have shown thus far, and how the lack of safety concerns will improve how they’re utilized.
Christopher Gottschalk, MD: Advantages of Eptinezumab and CGRP Inhibitors
The director of headache medicine and chief of general neurology at Yale Medicine spoke about the significance of having CGRP inhibitors in migraine treatment, and how eptinezumab fits into the treatment landscape.
2 Clarke Drive Cranbury, NJ 08512